Abstract
Hemolytic anemia after mitral valve repair and ring annuloplasty is uncommon when compared with mitral valve replacement. In this report we present the case of a 67-year-old woman who had undergone mitral valve repair with a Duran band and developed hemolytic anemia. Most patients with severe hemolysis after mitral valve repair undergo reoperation. However, in the present case, the hemolysis was found to be secondary to systolic anterior motion of the mitral valve and left ventricular outflow tract obstruction and was treated without the need for reoperation.
Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
MeSH terms
-
Adrenergic beta-1 Receptor Antagonists / administration & dosage
-
Aged
-
Anemia, Hemolytic* / diagnosis
-
Anemia, Hemolytic* / etiology
-
Anemia, Hemolytic* / therapy
-
Echocardiography, Transesophageal / methods
-
Female
-
Humans
-
Metoprolol / administration & dosage*
-
Mitral Valve Annuloplasty / adverse effects*
-
Mitral Valve Annuloplasty / methods
-
Mitral Valve Insufficiency / diagnosis
-
Mitral Valve Insufficiency / surgery
-
Mitral Valve Prolapse / diagnosis
-
Mitral Valve Prolapse / surgery
-
Mitral Valve* / diagnostic imaging
-
Mitral Valve* / pathology
-
Mitral Valve* / physiopathology
-
Postoperative Complications* / blood
-
Postoperative Complications* / etiology
-
Postoperative Complications* / physiopathology
-
Postoperative Complications* / therapy
-
Treatment Outcome
-
Ventricular Outflow Obstruction* / diagnosis
-
Ventricular Outflow Obstruction* / etiology
-
Ventricular Outflow Obstruction* / physiopathology
-
Ventricular Outflow Obstruction* / therapy
Substances
-
Adrenergic beta-1 Receptor Antagonists
-
Metoprolol